Immunotherapy with targeted radiation for solid tumors
Part of Cancer clinical trials.
This trial tests combining immunotherapy (checkpoint inhibitors) with precisely-targeted radiation pulses to see if this approach works better against solid tumors. It may help people who are already on or starting immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (liver cancer can be diagnosed by imaging)
- Your daily activity level is mostly okay (ECOG 0-2: able to do light work or self-care)
- You are already getting or about to start an immunotherapy drug called a checkpoint inhibitor
- You have at least one tumor that can be treated with radiation and can be measured on scans
- You do not have brain or spinal cord spread
- You are not pregnant or breastfeeding
- You have not had radiation to the same tumor area before
- You do not have serious health issues like uncontrolled infection, heart failure, or unstable psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of radiation therapy and two immunotherapy drugs (Iparomlimab and Tuvonralimab) for people whose solid tumors have returned or spread and are too large for standard surgery. The goal is to shrink the tumor and control the cancer.
This trial tests if a special type of radiation (pulse radiotherapy) can help your immune system fight cancer when it's not responding well to immunotherapy. It's for people with lung cancer that has spread to five or more areas and is growing despite treatment with PD(L)-1 inhibitors.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
This trial tests whether adding targeted radiation to your metastatic tumors can help your immunotherapy work better. It is for people with advanced solid tumors that have spread to 3-10 spots and who have been on immunotherapy for at least 3 months.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial studies whether a more intensive form of targeted radiation, combined with immunotherapy (immune checkpoint inhibitors), can work better and be safe for people with advanced non-small cell lung cancer. You may be considered if your tumor is limited in size and you’re able to receive both treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.